Treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2516990

The invention relates to the use of Interferon-.szlig. (IFN -.szlig.) for treating and for preventing Alzheimers disease (AD), Creutzfeld-Jakob disease (CJD) or Gerstmann-Sträussler-Scheinker disease (GSSD). It further relates to the use of IFN -.szlig. in combination with an Alzheimer's disease treating agent for treating and/or preventing Alzheimer's disease. The use of IFN - .szlig. in combination with a cholinesterase inhibitor for treating and/or preventing early-onset Alzheimer's disease is preferred.

L'invention concerne l'utilisation d'interféron-.szlig. (IFN-.szlig.) pour le traitement et la prévention de la maladie d'Alzheimer, de l'ESB humaine ou du syndrome de Gerstmann-Sträussler-Scheinker. Elle concerne en outre l'utilisation d'IFN-.szlig. en association avec un agent de traitement de la maladie d'Alzheimer pour le traitement et/ou la prévention de la maladie d'Alzheimer. De préférence, on utilise l'IFN-.szlig. en association avec un inhibiteur de la cholinestérase pour le traitement et/ou la prévention de la maladie d'Alzheimer à début précoce.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1349219

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.